Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 4901-4905, September 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delia, D.
Right arrow Articles by Della Porta, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delia, D.
Right arrow Articles by Della Porta, G.

Clonal Immunoglobulin Gene Rearrangements and Normal T-Cell Receptor, bcl-2, and c-myc Genes in Primary Cutaneous B-Cell Lymphomas1

Domenico Delia2, Maria G. Borrello, Emilio Berti, Marco A. Pierotti, Daniela Biassoni, Raffaele Gianotti, Elvio Alessi, Maria G. Rizzetti, Ruggero Caputo and Giuseppe Della Porta

Division of Experimental Oncology A, Istituto Nazionale Tumori [D. D., M.G. B., M. A. P., D. B., M. G. R., G. D. P.], and First Clinic of Dermatology, University of Milan [E.B., R. G., E. A., R. C.], Milan, Italy

Fourteen cases of primary cutaneous B-cell lymphomas were investigated at the immunohistochemical and molecular level to further characterize this newly defined entity. Neoplastic cells from all cases, phenotyped with a panel of monoclonal antibodies, were positive for HLA-DR, for the B-cell markers CD19, CD22, but not CD23 (except one case), and negative for the T-cell marker CD2. Monoclonal immunoglobulin light chains were demonstrated in six cases. The reactivity with the Ki-67 monoclonal antibody indicated that the neoplastic cells are proliferating. In five biopsies the presence of dendritic cells infiltrating the neoplastic areas was revealed using the monoclonal antibody Kim4b.

By Southern blot analysis, clonal rearrangement of the immunoglobulin heavy chain gene (involving one or both alleles) was shown in 12 of 14 cases and of the light chain genes in 13 cases. The bcl-2 oncogene, normally involved in nodal follicular lymphomas, was in germ-line configuration. The c-myc and the ß and {gamma} chain genes of the T-cell receptor were also in the germ-line configuration. None of the cases presented Epstein-Barr virus sequences.

These data indicate that primary cutaneous lymphomas of B-cell origin share morphological and phenotypic similarities with the nodal B-cell lymphomas of follicular histotype, are proliferating, and express in 45% of cases clear monoclonal immunoglobulin light chain; the molecular analysis confirms the B-cell derivation and the monoclonal nature of this neoplasia; it also shows that neither bcl-2 nor c-myc oncogenes are involved and that no inappropriate rearrangements of the T-cell receptor genes are found in this lymphoma.

1 This work was partly supported by a grant of the Italian National Research Council, Progetto Finalizzato Oncologia (Contracts 86.00455.44 and 87.01214.44) and by the Associazione Italiana Ricerche Cancro.

2 To whom requests for reprints should be addressed, at Division of Experimental Oncology A, Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy.

Received 6/10/88. Revised 1/27/89. Revised 5/18/89. Accepted 5/26/89.




This article has been cited by other articles:


Home page
Arch DermatolHome page
R. Bergman, P. J. Kurtin, L. E. Gibson, P. R. Hull, T. K. Kimlinger, and A. L. Schroeter
Clinicopathologic, Immunophenotypic, and Molecular Characterization of Primary Cutaneous Follicular B-Cell Lymphoma
Arch Dermatol, April 1, 2001; 137(4): 432 - 439.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Cerroni, E. Arzberger, B. Putz, G. Hofler, D. Metze, C. A. Sander, C. Rose, P. Wolf, A. Rutten, J. M. McNiff, et al.
Primary cutaneous follicle center cell lymphoma with follicular growth pattern
Blood, June 15, 2000; 95(12): 3922 - 3928.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. L. Pandolfino, R. S. Siegel, T. M. Kuzel, S. T. Rosen, and J. Guitart
Primary Cutaneous B-Cell Lymphoma: Review and Current Concepts
J. Clin. Oncol., May 10, 2000; 18(10): 2152 - 2168.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.H.H. Kramer, J. Hermans, E. Wijburg, K. Philippo, E. Geelen, J.H.J.M. van Krieken, D. de Jong, E. Maartense, E. Schuuring, and P.M. Kluin
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
Blood, November 1, 1998; 92(9): 3152 - 3162.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.